DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM FOR CHRONOTHERAPEUTIC RELEASE OF METOPROLOL SUCCINATE USING PRESS-COATING METHOD Authors: Saravanan G
ABSTRACT
The current examination was done on the turn of events and assessment of Pulsatile Drug
Delivery System for Chronotherapeutic Release of Metoprolol Succinate. The medication is
having a biological half-life of 3-7 hours and is intended for the treatment of Hypertension. In
the current examination time discharge tablets were set up by press-coating method. The plan
included two stages. First was to prepare core tablets and second included the coating of core
tablets with polymers. Super disintergrants like Cros-Povidone, Cros–Carmellose Sodium and
Sodium Starch Glycolate were utilized for the formulating of core tablets and assessed for precompression
and post compression boundaries as to recognize quick discharge character of
medication for formulations. The best formulations among them having higher medication
discharge with less span of time was selected and again concentrated further by coating with
various polymers in various comcentrations to hinder the medication discharge and to
accomplish time-discharge pulsatile tablets. Natural polymers like Xanthum gum and Guar gum
were utilized for coating as these are biodegradable and non-poisonous, which hydrate and swell
on contact with fluid media. At long last, the created formulations were assessed for its physico
chemical properties, dissolution rate, drug discharge mechanism and kinetics, stability and the
best formulation was chosen. Along these lines from this investigation, Consistent lag time, immediate release of the drug and the prerequisites for creating Pulsatile Drug Delivery System
for chronotherapeutics was accomplished with the created formulation.
Keywords: Pulsatile, Chronotherapeutics, Metoprolol Succinate, Super
disintergrants, Natural polymers, lag time Publication date: 01/02/21 https://ijbpas.com/pdf/2021/February/MS_IJBPAS_2021_5341.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2021/10.2.5341